Insights made into how Red Hair Colour (RHC) trait variants may increase melanoma risk
30 November 2023
The Goding lab have worked in collaboration with Bill Pavan’s group of the National Human Genome Research Institute, at the National Institutes of Health (NIH), to uncover the transcriptomic profile of MC1R-inhibited melanocytes at single-cell resolution in Pigment Cell & Melanoma Research.
Ludwig Oxford DPhil candidate receives MSD Teaching Excellence Award
10 November 2023
Ludwig Oxford’s Olly Featherstone has been awarded an Early Career Excellent Teacher award by the Medical Sciences Division Teaching Excellence Awards.
New DPhil studentships in Cancer Science available for 2024 intake
30 October 2023
Boccellato Byrne Lu Rittscher Schuster-Böckler Tomkova Van den Eynde White
Ludwig Oxford supervised DPhil studentships in Cancer Science are now being advertised for the 2024 intake
Collaboration announced between Satisfai and University of Oxford to develop AI methods of evaluating Barrett's oesophagus
9 October 2023
An agreement between Satisfai Health Inc and the University of Oxford will forward the automated assessment of Barrett’s oesophagus, designed to determine patients with the highest risk of developing oesophageal cancer.
Acetylation reprograms MITF target selectivity and residence time
28 September 2023
Ludwig Oxford’s Colin Goding and his lab reveal an acetylation-mediated switch that suppresses differentiation and provides an explanation of why a human K206Q MITF mutation is associated with Waardenburg syndrome.
A role for ASPP2 in Hepatitis C infection
28 September 2023
Ludwig Oxford researchers in the Lu lab uncover new insights into the role of ASPP2 in Hepatitis C virus replication and transmission.
Vacancies: Assistant and/or Associate Professor Level Cancer Researchers
21 September 2023
The University of Oxford and Ludwig Cancer Research are adding to our growing group of cancer researchers. We are seeking individuals at early to mid-stage career stages (Assistant or Associate Professor level).
Ludwig Oxford Professor Announced
12 September 2023
Congratulations to Richard White who has been successful in the 2023 University recognition exercise.
Ludwig Oxford’s Dr Mehdipour in one of three University of Oxford teams shortlisted for Cancer Grand Challenges funding
5 September 2023
Dr Parinaz Mehdipour is a member in one of the 12 teams shortlisted for funding from Cancer Grand Challenges, seeking to understand retrotransposable elements in cancer.
Ludwig Oxford welcomes new Leadership Fellow Dr Marketa Tomkova
25 August 2023
Our new Leadership Fellow launches a research group in computational cancer genomics
Ludwig Oxford’s Richard White awarded for his Outstanding Research by the Society for Melanoma Research
18 August 2023
Richard White has been named for the 2023 Outstanding Research award by the Society for Melanoma Research
Comparative analysis of ADO and PHD enzymes allows researchers to better understand their co-evolution and integration into oxygen homeostasis mechanisms
17 August 2023
Ludwig Oxford’s Peter Ratcliffe and Tom Keeley have undertaken a comparative analysis of a number of enzymes involved in the adaption of cells to oxygen level changes.
Ludwig Oxford clinical trial shows Immunochemotherapy outcomes predicted by tumour monocyte content
11 July 2023
Lu Schuster-Böckler Van den Eynde
An analysis of samples obtained from a uniquely designed window-of-opportunity clinical trial (LUD2015-005) has shown that high tumour monocyte content (TMC) is an unexpected predictor of greater overall survival in inoperable oesophageal adenocarcinoma (OAC) patients.
Ludwig Oxford labs awarded Silver in laboratory sustainability
15 June 2023
Laboratories at Ludwig Oxford have been awarded a Silver certificate for sustainability following the Laboratory Efficiency Assessment Framework (LEAF).
p53 inhibitor iASPP acts as a surprise pancreatic cancer suppressor
9 June 2023
Ludwig Oxford’s Xin Lu shows an unexpected suppression of KRAS and inflammation driven pancreatic cancer by the p53 suppressor iASPP.
Hypertension treatment drugs may play a role in boosting clinical immunotherapy
8 June 2023
Team from the Van den Eynde group have discovered that some molecules previously used to treat hypertension might also help the immune system to better fight cancer cells
Oxford DeLIVER research attracts 1000 patients for innovative Pearl clinical study
30 May 2023
1000 patients have been recruited for the Pearl study within the DeLIVER programme.
Ludwig Oxford scientists participate in symposia for aspiring your scientists
19 May 2023
As part of the Scientists in Schools programme, Dr Carol Leung and Oliver Featherstone give talks to students on their work in cancer research.
Ludwig Oxford's Professor Yang Shi elected to Academy of Medical Sciences
18 May 2023
Ludwig Oxford's Yang Shi has been announced as a Fellow of the Academy of Medical Sciences
Ludwig Oxford Principal Investigators host interns for NDM’s summer studentships
2 May 2023
Three research teams within Ludwig Institute for Cancer Research Oxford are looking to host undergraduate and Masters students as an exciting opportunity to experience active research in an Oxford University Institute.